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Public health  officials and  physicians  are concerned  about  possible  development of  bac- 
terial  resistance  and potential  effects on  human  health  that  may  be related  to the  use  of 
antimicrobial  agents  in livestock feed. The focus of  this research  is  aimed at determining 
the economic effects that subtherapeutic bans of anti~nicrobials  would have on both swine 
producers  and  consumers. The res~~lts  show  that  a  ban  on  growth  promotants  for  swine 
would he costly. totaling $232.5  nill lion  annually. with swine producers sharing the larger 
portion in the short run  and consurners sharing the  larger portion in  the long run. 
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Food  animal production  in  the United States  therapeutic concentrations of antibiotic or 
uses  antimicrobial  agents to promote animal 
welfare and to enhance the efficiency of live- 
stock  production. Of the total  antibiotic pro- 
duction for both human treatment and animal 
purposes, approximately 25% is used in food 
animals and 90% of that portion has been re- 
ported  as being  used  in  subtherapeutic  con- 
centrations for disease control and as growth 
promotants (Angulo; APHIS). 
Antimicrobial  agents have been  added  to 
feed and used extensively in swine production 
since their introduction in the early 1959s (Ra- 
dostits,  Leslie,  and  Fetrow).  Swine  perfor- 
mance is potentially  improved by using  sub- 
chemotherapeutic  drugs  to  increase  rate  of' 
gain or improve feed conversion (FDA). Be- 
cause of  the  economic benefit  to producers, 
antimicrobial dl-ugs are used in about 90%)  of 
the starter feeds, 75% of the grower feeds. and 
over 50% of the finisher feeds (Cromwell). 
Growth promotant or subtherapeutic use of 
antimicrobials  administered  in  animal  feeds 
has been strongly criticized as a sel-ious public 
health  threat,  causing  life-threatening  infec- 
tions that are resistant to antimicrobial therapy 
(Angulo; Witte). This concern has developed 
around the following issues: (1) subtherapeutic 
use of antimicl-obials in  animal feeds creates 
antimicrobial-resistant bacteria; (2) if subther- 
apeutic use  were eliminated, the level  of re- 
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search Council  1998b). However, in  spite of 
these claims, there appears to be  no clear-cut, 
definitive answer regarding whether subthera- 
peutic  use  causes  adverse effects  on  human 
health (Mathews). Nonetheless, it appears that 
human  health  officials  are  moving  toward 
withdrawing  antimicrobials  that  are  used  for 
growth  promotants  in  animals if  these  drugs 
are  also  ~lsed  for  human  therapeutics  (Her- 
rick). 
Earlier studies on the economic impacts of 
bans on antimicrobial use in swine production 
conducted  in  the  1970s indicated an  increase 
in  the  market  price of pork and  a 4-20%  re- 
duction  in  the quantity of pork supplied to the 
market  (Gilliam et al.; USDA).  In  1985, the 
Animal  Health Institute estimated that growth 
promotants  save hog  producers  an  estimated 
two billion dollars in annual production costs. 
Shifts in  technology  and changes in  manage- 
ment systems would likely alter these results, 
which were obtained more than  15 years ago. 
In two of the more recent economic studies 
dealing  with  the  ban  on  subtherapeutic  anti- 
microbials  in  swine  production.  a  basic  as- 
sumption was made that  would  appear to se- 
riously  flaw  the  results  of  these  reports 
(Manchanda;  Wade  and  Barkley).  Both  of 
these studies assumed that there would be an 
increase in the demand for pork of 5% because 
of perceived  improvements by  consumers that 
pork  produced  under  these  bans  would  be 
more wholesome and less likely to contain an- 
tibiotic residues. This assumption seems to be 
unfounded because further decrease in the ex- 
tremely  low level of current antibiotic residue 
rates  would  be  unlikely. The study by  Wade 
and Barkley  reported  net  econornic gains for 
both producers and consumers due to the pro- 
posed  ban  on antibiotics.  If  the  demand  for 
I  While many of the antibiotics used in  swine (\re 
APHIS for a list of them) arc not  approved for human 
use.  they  are  still  member.;  of  drug  families  that  in- 
clude human  antibiotic\. Ractcria could develop reib- 
tmcc in  such a way  that  it  was resi\tanl  to  all  drugs 
within  n  drug family. Most bacteria  that  infect  swinc 
do not infect hum~ins.  But the t'car is that resistant hac- 
tcria could mutate and inl'ecl  li~~mons  or that the resis- 
lance co~~lci  he  tr;ln\fcrrcd  to  human  bacteria through 
plasmid\  (In\titulc of  Medicine). 
antibiotic-free pork were genuine, market so- 
lutions'  or labeling would be appropriate rath- 
er than an outright ban through regulation. 
The most  recently  published  economic 
evaluation (National Research Council  1998a) 
of the effects of a ban  on  subtherapeutic  use 
of ~lntimicrobials  in swine production also in- 
cluded  some  assumptions  and  methods  that 
were  questionable. This  study  assumed  that 
there would be no change in consulnption with 
a concomitant increase in  the market price of 
meat. No  elasticity measurements were includ- 
ed in this study that would make adjustments 
for changes in  consumer demand due to price 
increases  and  provide  for economic changes 
related  to substitution effects among compet- 
ing goods, such as beef  or poultry. 
The current climate of increased regulatory 
pressures by  health officials and notable defi- 
ciencies or flaws in previously reported studies 
on  the economic impact of  restricted  antimi- 
crobial use policies indicate the need to obtain 
better quality information about this potential 
economic problem facin~  the U.S. pork indus- 
try. 
The objective  of  this  study  is  to  develop 
useful economic estimates of the impact of po- 
tential restricted-use policies fhr antimicrobial 
agents  used  in  swine  production  as  growth 
promotants.  By  using  a model  similar to that 
used by  Wohlgenant, the economic impacts of 
banning  antimicrobials  in  swine  production 
are measured by the changes in producers'  and 
consumers'  surplus. 
Estimation of the Surplus Changes from 
the Bans of Antimicrobials 
Wohlgen~int's  model allows feedback between 
the beef  and pork  markets and  can be used to 
measure  the  changes  in  producers'  and  con- 
sumel-s' surplus due to shifts in both demand 
and supply curves. Our purpose is to measure 
the changes in producers'  and consumers' sur- 
'  Organic pork  is available at relatively high  prices 
in  organic-food stores, but  consumption  is  low. Pro- 
clucing organic pork  requires much  rriore than just  us- 
ing no ~~~htlicrupeutic  antimicrobials, so  organic pork 
prices would greatly overestimate the cost of a ban. plus in beef,  pork, and poultry. Wohlgenant's 
model is modified in two dimensions: first, the 
two-commodity model is extended to a three- 
commodity  model;  second,  the  parameters 
corresponding to the shifts in  demand curves 
are set equal to Lero and thus only effects of 
supply  shifts  are  considered.  Note  that  the 
model  used by Wohlgenant assumes a parallel 
shift in  supply. When the real shift in supply 
is not  parallel, the impact  might  he  overesti- 
mated or underestimated  (Taylor). Given that 
over 90%  of  swine  producers  use  subthera- 
peutic antibiotics. a parallel shift appears to be 
a reasonable assumption. Explicitly, the mod- 
ified  model  is 
( Ib)  p:': = s w:% 
I  I  I' 
(Ic)  X  =  I  - S,)nIWf + Q*  , ,  and 
where  asterisks  denote  approximate  relative 
changes (i.e., X* = dXIX):  subscripts 1. 2,  and 
3 denote beef, pork, and poultry. respectively; 
Q  represents  quantity  of  retail  product:  P  is 
retail price; X is  quantity of  farm product, W 
is farm  price:  qIi is  the elasticity of  demand 
for the jth retail product  with respect to price 
of the ith  product; o,  is the elasticity of  sub- 
stitution  between  the farm  protiuct  and  mar- 
keting inputs in  producing the jth  product: S, 
is the farmer's cost share of theQth retail prod- 
uct; >:,  is the elasticity of supply of thejth farm 
product; and 6, is the relative decrease in  pro- 
duction cost for the jth farm product. 
Once  the  parameters  in  equation  (I) are 
~iven,  the  values of the  variables  with  aster- 
isks can be determined by  solving the eclua- 
tions simultaneously. Using the total farin rev- 
enue and total consumer expenditures on each 
product  and  dropping  the  commodity  sub- 
scripts  to  simplify  notation.  changes  in  pro- 
ducers'  and consumers'  surplus can be calcu- 
lated as 
(2h)  ACS  = PQP'"(]  t 0.5Q:"), 
where IPS denotes the change in producers' 
surplus and ACS  denotes the change in con- 
sumers'  surplus. The total farm revenue.  WX, 
and total consumer expenditures. PQ, in each 
of the markets are predetermined. 
All  parameters  necessary  to  apply  the 
equations in (1) and (2), except the parameter 
representing the change in  production  costs, 
will  be  based  on  other  researchers'  results 
(e.g.,  Brester  and  Schroeder;  Wohlgenant). 
The production  cost change parameter,  k, is 
determined  by  simulations described  as l'ol- 
lows. 
Production Cost Changes Due to Banning 
Use of Growth Promotants 
The production  cost changes due to banning 
the use of antimicrobial growth promotants are 
~neasured  indirectly  by  the net  benefits  from 
using  growth  proniotants.  Three key  conipo- 
nents were identified as the most important for 
contributing  potential  economic  advantages 
for growth promotant use at the producer lev- 
el:  (a)  improved  feed  efficiency  over  drug 
cost,  (b)  reduced  mortality  rate,  and  (c) re- 
duced sort loss at marketing. The net econon- 
ic benefit for growth prornotants in swine pro- 
duction is the sum of these components. The 
per  animal net  benefits  are then  used  to cal- 
culate the net benefit at the industry  level. 
Econo~nic.  Benqfir frorn Improvrcl F~~c.tl 
Eflic.ic,nc:v 0vc.r  Dr~r,q  Cosr 
The stochastic  relationship between  the eco- 
nomic benefit per pig and the improvement in 
feed to gain conversions (FIG) in swine pro- 
duction is modeled as 
(3)  economic benefit 
where oc  and p  are the parameters to be esti- 
niatcd  and  t. is  a random  variable  with  zero 
mean. Improvement in  FIG  is a random  vari- 
able with a probability  distribution  to be de- 
termined. 
Scientific literature was reviewed  to deter- 
mine  the  probability  distribution  ol  the  im- 
provenlent in FIG and the parameters cx  and p. 492  Journal of Agriculturul and Applied Econonzic~~,  Dec.ernher 2002 
This literature search provides the data shown 
in  Table  I. Reports were restricted  to feeding 
trials using  antimicrobial compounds that are 
presently available for use in swine; reports on 
those  compounds  under  development  or  not 
yet  approved for use  by  FDA  in  swine feed 
were excluded. Data from feeding trials  lim- 
ited to extremely brief  periods of the produc- 
tion  cycle, such as those associated with seg- 
regated  early weaning programs and from the 
report  based  on  producer  surveys  instead  of 
actual  feeding trials, were excluded from cal- 
culations. 
Improvements  in  feed-to-gain  ratio  (FIG) 
for  subtherapeutic  levels  of  antimicrobials 
were  reported  as ranging  from -  1%  (a de- 
crease)  to  5%  or  greater for  growerlfinisher 
hogs.  The  mean  improvement  in  FIG  was 
2.74%,  with  a  standard deviation  of  I .88%, 
based  on  16 different  values  in  the literature 
from feeding trials covering significant periods 
of  the growerlfinisher phase of swine produc- 
tion. These data best fit a normal  distribution 
compared with alternative distributions. Thus, 
FIG is assumed to follow a normal distribution 
with 2.74 as the mean and  1.88 as the standard 
deviation (Figure 1). 
A linear regression is used to determine the 
parameters  cx and p. Economic values derived 
from drug use during extremely brief  periods 
of  the  production  cycle  or  from  therapeutic 
dose rates were excluded from the regression 
analysis. The regression  based on the data in 
Table  1  shows the following estimated equa- 
tion: 
(4)  economic benefit 
=  1.68  +  0.66 (improvement in FIG) 
(0.46)  (0.16) 
This result  is  used  to estimate the  economic 
benefit per pig from the improvement in FIG. 
Economic Benefit ,from Reduced 
Mortality Rate 
Subtherapeutic  use  of  antimicrobials  affects 
mortality rates, especially on younger pigs, al- 
though these effects are not well documented. 
Only two of the published reports in  Table  1 
provided  data about  differences  in  mortality 
rates associated with the use of antimicrobial 
agents.  Walter,  Holck,  and  Wolff  evaluated 
therapeutic  levels  of  tiamulin  and chlortetra- 
cycline fed from  1 1  weeks of age for a period 
of  16 weeks to more than  1,000 modern cross- 
bred  lean  genotype barrows in  a commercial 
swine production system. Treatments were di- 
vided  among continuous delivery  of  medica- 
tion  in  feed,  "pulse"  delivery  of  medication 
for 7 days administered every 2 or 3 weeks, 
and  a nonmedicated control  group. Mortality 
rates for pigs in these groups were 0.55, 1.92, 
and 5.2296, respectively, with both medication 
groups having significantly less mortality than 
controls. Gourley evaluated low-level  contin- 
uous  and high-level  "pulse"  (I  week  out of 
4) medication regiments for delivering chlor- 
tetracycline in feed to 576 growerlfinisher pigs 
from a lean genotype, high health  swine herd. 
The third treatment was a nonmedicated con- 
trol  group. The mortality  rates  for the  three 
treatment groups were 2.60, 2.08, and 3.1  3%, 
respectively.  Although both medicated  groups 
had  lower  mortality  than  the  nonmedicated 
group, none of the three mortality levels were 
significantly different from the others. The av- 
erage mortality benefit from the two published 
reports is 1.43%, but the nonmedicated control 
group in  the  Walter,  Holck,  and Wolff  study 
had  death  losses  above  those  normally  ex- 
pected  in  commercial  herds.  We  therefore 
model  the  mortality  benefit  associated  with 
growth promotants as a symmetric triangular 
distribution with minimum 0, most likely 0.75, 
and maximum  1.5%. 
The market price used  for hogs is  $45.00 
per cwt. This price is based on an approximate 
10-year  average  market  hog  price  (Walter, 
Holck, and Wolff). The market price of  hogs 
is used indirectly  to establish the value of 40 
Ib. feeder pigs needed to calculate benefits as- 
sociated  with  reduced  mortality  rates.  Using 
current  feeder  pig  pricing  schedules  as  a 
guideline  (Iowa  Department  of  Agricultural 
Market  News),  we  also assume that  heavier 
feeder pigs are worth $0.45 per pound for ad- 
ditional  weight  over 40 lbs. Weights  of  pigs Table 1.  Reported Effects of Growth Promotants Fed to Swine on Feed Efficiency and the Associated  Economic Benefits (F:  G is  feed to 
gain; NR is not reported) 
Net 
Economic  Used  to Estimate 
% l~nprovement Advantage  Improvement in 
Drug  in  F :  G Ratio  ($/pig)  Comment  F :  G Ratio?  Author(s) 
Carbadox  5.60  1.36  Early  weaning period only  N  0,'  Anderson, Campbell. and Walter 
Tiamulin + chlortetracycline  7.50  2.66  No" 
Carbadox  6.90  NR  To  35 kg  Noh  Cromwell and Stahly 
Tiamulin  5.70  NR  To 30 kg  Noh 
Tiamulin  3.10  NR  To 57 kg  Yes 
Chlortetracycline  1.72  2.17'  Grower/finisher  Yes  Gourley 
4.50  NR  Historical data  Yes 
Chlortetracycline  1.03  2. I ?  Dose:  50 glton  Yes  Gourley and Wolff 
0.34  1.86'  100 g/ton  Yes 
Bambermycin  3.74  NR  Five different locations  Yes  Hagsten, Grant, and Meade 
Tylosin  2.30  NR  Yes 
Chlortetracycline  6.42  NR  Producer survey  Nod  Losinger 
Ty lusin  5  .OO  4.88'  Commercial  farms  Yes  M. .k'  LIC  lnnoll 
Carbadox  + virginiarnycin  5.47  NR  NRC diet  Yes  Schwartz 
3.5  1  4.8SL  High density diet  Yes 
Chlortetracycline  0.67  NR  Seven-state st~~dy  Yes  Speer 
Various  -0.33  NR  Six-state study  Yes 
Tylosin  4.57  NR  Dirt  lots  Yes 
Bacitracin  3.30  NR  Analysis of 85 trials  Yes  Tillman 
Methylene disalicylate  2.40  NR  High  lean genetics  Yes 
Tiamulin + chlortetracycline  3.80  3.87'  Lean genotype pigs  Yes  Walter, Holck, and Wolff 
Data were limited to early weaning period. 
h Data were limited to only a portion of  the grower/finisher phase. 
Economic data that were used to develop ecc~nomic  association with corresponding improvements in F:  G ratio. 
,J  Data  were developed from a producer  survey and not based upon  feeding trials. 
Ecollornic  data thar  were not used  because antimicrobials  were fed at therapeutic rates. 494  Jolrrn~~I  o/ Agric.~rltrrrtr/  crr~ti  Apl?lred E(~~JI~OII?~C\,  Dec errzher 2002 
Table 2.  Sort Loss Discount\ for Underweight Hogs and Differences in Distributions between 
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function was used to detcrminr climulative proportion\ for each weiyht range within each group  inputs for c;~lculating 
difference\ in clistributions. 
that  wo~rld  not  die  due  to  feeding  growth 
promotants is modeled  a\  a  tr~angular  dictri- 
bution with a minimurn value of 40. most like- 
ly value of 60. and maxirnum value ot 80 Ibs. 
Ecot~oniic.  Bcnr<fit  ,fronl Rc)clr~c,rt/  Sort Loss 
c~t  ,Vllrrketitzg 
When the weights of ~narket  hogs fall outside 
of  the  packel--specitied weight  range.  pricing 
discounts  are  applied,  especially  for  light- 
weight  hogs,  based  on  price  schedules  or 
"grid"  pricing. The term "sort  loss"  has been 
used by the swine industry to iiescribe the dot- 
lar  loss related  to these  market  hogs.  which 
receive  price  discounts.  Growth  prornotants 
irnprove the i~niforrnity  of average daily gain 
and therefore reduce the  ending weight  vari- 
ability and associated sort loss for market hogs 
(Gourley:  Gourley and Wolff; Tillman). The 
size  of the  sort  loss  benefit  would  vary  uc- 
cording to the  type  of  feeding man;igement. 
Production  systems  using  targeted  days  on 
feed would achieve potentially greater benefits 
related  LO reclucrd sort loss conlpared with tar- 
geted  marketing  weight management systems 
because the tirne schedule for a targctcd days 
system ~vo~rld  typically provide  less opportu- 
nity for delayed niarketing to allow additional 
gain for lighter weight pigs. A report by Till- 
rnan  provided  data on avel-age ending weight 
and  standard  deviations  for the  effect  of  a 
growth  promotant  on  reducing  sort  loss  in 
rnarket  hogs compared with  a  control  group 
based  on  a  targeted  days on  feed production 
system. The normal distribution function was 
used  to determine cumulative proportions 
within each group. Then the cumulative pro- 
portions  were  used  as inputs  for calculating 
differences in distributions between these two 
groups. Sort losses at slaughter were based on 
grid pricing discour~ts  announced by Farmland 
for  underweight  hogs  (Table 2). These data 
provide  an overall mean value of $1.39 with 
standard deviation of $0.15 per hog benefit for 
growth  promotants  in  reducing  sort  loss  for 
targeted  days  production  systerns.  To avoid 
overestimating thc  benefit  from  reduction  in 
sort loss, it is assumed that this benefit would 
be  only  one third as  much,  i.e.,  mean $0.46 
with  standard deviation  $0.05 Ibr hogs  pro- 
cluced  under targeted  weight  production  sys- 
tems because of increased  opportunity  to al- 
low longer feeding periods to achieve desired Table 3.  Management of Swine Farms Related to Growth Promotant Use in  Growerminisher 
Pigs and Prevalence of All-InIAll-Out Production System 
Swine '95 Report 
Mean  SE 
Growth Pro~notant  Use 
Percent of  swine operations  91.3  2.0 
Percent of  growerlf niahrr hops on those operations  92.7  1.5 
Percent of  pigs receiving growth promotants  84.6 
Input used for simulation model  85.0  2.0 
Growerltinisher management 
Percent hops. all-inlall-o~~t  production system  51.0  2.2 
SOLII-ccs: Animal and Plant Health 111\prction  Sel-vice: Centers for Epidemiology and Animal Health 
market  we~ghts,  which  ~ould  reduce  the 
chance of  price  di\counts.  No benefit\  were 
included for any reduction in day\ on teed as- 
wciated with the use of growth promotant\. 
E.~tirnatirzg  the  Totc~l  Nct Ecorlotrric  Brnqfit.5 
clt Irltlrr.str~,  Lc~vc.1  bj. Sir17~rltrtiorl 
As  outlined  before,  the  total  net  economic 
benefits  l'rom  using  growth  promotants  are 
from three random sources, i.e..  normally dis- 
tributed impro\fenient in  FIG, triangularly dis- 
tributed  reduced mortality  I-ate, and  normally 
distributed  reduced sort loss at marketing. To 
estimate the total economic benetits, we need 
to convert the scale from producer level to in- 
dustry level. 
The  number  of  market  barrows  and  gilts 
slaughtered per  year is extrapolated from an- 
nual  USDA  livestock  slaughter summary re- 
ports for years  1994-2000.  These summaries 
report figures ranging from 86.5 to 96 million 
head  for  years  I996 and  1999. respectively. 
Based on these data, annu211 production of 100 
million  market  burrows  and  gilts  is  assumed 
for the simulation. 
The proportion  of  growerfiinisher pigs re- 
ceiving  antimicl-obials as growth  promotants 
and  the  proportion  of  growerttinisher  pigs 
managed  as all-inlall-out  are based  on popu- 
lation  estimates  from  the  Swine  '95  project 
(Animal and  Plant Health and Inspection Ser- 
vice;  Centers for  Epidcmiology  and  Animal 
Health) (see Table 3). We  project that XSYr  of 
growerlfinisher  pigs  would  receive  growth 
promotants  in  feed  and  that  55%  of  hogs 
wo~~ld  be raised in an all-intall-out growerltin- 
isher system. 
Once  the  probability  distributions  of  the 
three  sources of  economic benefits  at the in- 
dustry level are given, the total  net economic 
benefits are estimated by s~~tnming  the benefits 
of each of the three co~nponents.  The expected 
net benefit co~~ld  have been well approximated 
with analytical  methods by assuming normal- 
ity.  The  Monte  Carlo method,  however.  ac- 
commodates nonnormal distt-ibutions and pro- 
vides  a  convenient  way  of  calculating  the 
uncertainty of the estimate. 
Kesults 
Based on a 5.000 iteration simulation, the total 
estimated net  benetit l'or  subtherapeutic use of 
antibiotics in swine production was calculated 
as $2.76  i-  $0.56 per  hog as determined  by 
the  previously  described  components (Figure 
2). Although a wide spread in the value of this 
benefit  was  possible,  the  majority  of  values 
most likely to occur would range fi-om $2.37 
to $3.  I  I  per hog. The average benefit of $2.76 
pel- hog was used to calculate the proportional 
change in  production  costs for the swine in- 
dustry  and the I-esulting impact on economic 
values  related  to  changes in  supply  and  de- 
mand  of pork  in  the United States if  the use 
of  subtherapeutic  antibiotics  in  feed  were 
banned. If the resulting change in cost oS pork 
production  is  lower or higher than  assumed, 
all  nurnbers  change proportionately. The cal- 
culated  average  incl-cased cost of  production 
01'  $2.76 per hog due to loss of  the net benefits 396  .Io~lt-~iill  OJ' Agriclllr~ltul  UIZ~  Applied Ec~orlornic.~.  D~c,cr~zber  2002 
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Figure 1.  Distribution of Improvement in Swine Feed Efficiency Due to Growth Promotants 
;issociated  with  growth promotants was con- 
sidered to be the best estimate for figuring the 
cost  change listed  in  Table 4.  Two different 
sets of  supply  elasticities are considered  be- 
cause they are key parameters and there is lit- 
tle data on what values to use. 
Given all  parameters  and data in  Table  1. 
the  variables  with  asterisks  in  equation  (I), 
i.e.,  the  retail  products,  retail  prices,  farm 
products,  and  farm prices  for the three com- 
modities, are obtained  by  solving the simi11- 
tancous ecluations  (1). Substituting  the  solu- 
tion  for (I) into (2). we obtained  changes in 
producers'  and consumers' s~lrplus.  By setting 
specific parameters equal to zero, the changes 
in producers' and consumers' surplus obtained 
are the ones due to banning subtherapeutic an- 
tibiotics in swine only or both swine and poul- 
try production. 
The total annual loss in the short run would 
be $242.5 million (the sum of the tirst row in 
Table 5).  Table 5 shows that, in the short run, 
the estimated loss borne  by  swine producers 
would be $153.5  million. In  the long run, the 
swine producer surplus loss  would  be  $99.2 
million  if  the elasticity  for each of  the com- 
modities is 0.5, ancl only $62.4  nill lion  with a 
more elastic supply. The results from the two 
sets of long-run elasticities show that a change 
in the elasticity does not change the total  in- 
% per Hog 
Figure 2.  Distribution of Net  Benefit Values fur Growth Promotants Bror-set7  c,t  trl.: B~li~iliilg  S~lhthercrpe~lti~.  Atltihioric.~  in  Sn,irfc  497 
Table 4.  Estimates of Parameter Values for the U.S. Beef. Pork, and Poultry Industries 
Value 
Beef  Pork  Poultry 
Price elllaticity of  demand for beef  (qI)  -0.6  0.1  0.2 1 
Price elasticity of  demand for pork  (q:)  0.  I 4  -0.35  0.04 
Price elasticity of  demand for poultry  (q3)  0.05  0.07  -0.3 
Elasticity of  sobstitution  ((T)  0.72  0.35  0.35 
Elasticity of  farm supply. short run  (r,,)  0.1 5  0.2  0.2 
Elasticity of  farm supply. long run  (E,  ,,)  0.50  0.50  0.50 
Elasticity of  farm \upply, long run  (E, ,,,)  0.70  I  1 
Farmer's  share of  consumer's dollar (S)  0.49  0.4  0.4 
Increase  in production costs,' (k)  0  0.02023  0 
Total  farm revenue (WX)  $35 bil.  $12 bil.  $17 bil. 
.'The prolxwtional  change  in  productit>n co\t\  was calculated  as increased  production  cosl  per  hog  due  to growth 
p1-011iota11t  hi~11  = $2.76, $2.76 X  84.6';  ~~tili/i~tion  of  growth promotants - $2.33 pcr  hog  for industry, weight of onc 
pi:  =  256  It>. = 2.56 cwt.  market  \:~lue  per pig  = $45/cwt X  2.56 =  91 15.20, production cost  increase  =  $2.331 
$1 15.20 = 2.023%. 
pact' but on1  y affects the allocation of the ben- 
efit  change between  the  producers  and con- 
sumers. The results  reported  in  Table  5  are 
based  on  $45.00  per  cwt  market  price  for 
hogs.  A  sensitivity  analysis  was  done  for 
$40.00  per  cult  and $50.00 per  cwt.  respec- 
tively.  If  the market price for hogs decreases 
from $45.00 per cwt to $40.00 per cwt, both 
producers  and consumers  would  bear  11.1  % 
less loss in both the short and long run. If the 
market price increases from $15.00 per cwt to 
$50.00 per cwt, the loss borne by  the produc- 
ers and consumers would  increase by  I  1.  I % 
in both the short and long run. 
' Simulations were  also considered  where the ban 
wa\ allvwed to  apply to  poultry and therefore poultry 
supply nl\o .shifted. Bccause of  the low price elasticity 
between  pork  and poulrry.  it does not  make much  dif- 
ference to  swine producers as to  whether the ban  in- 
cluded swine only or ;~lso  included poultry. 
Measuring the benefits  is  beyond  our ex- 
pertise, but we can give the reader some per- 
spective based on other literature. The cost ef- 
fectiveness of regulations varies widely (Tengs 
and Graham). Hahn. Lutter. and Viscusi focus 
on  the  mortality  benefits  of  regulations  be- 
cause  they  argue  the other  benefits  are  less 
than  10% of mortality benefits. Viscusi (p. 73) 
reports that estimates of the value of a human 
life were 3-7  rnillion  1992 dollars (4-9  mil- 
lion  2002 dollars). Angulo, Tauxe. and Cohen 
estimated  that  I07r  of  salmonella  infections 
becoming resistant to fluoroquinolones would 
cause  19 deaths a  year.  Swine have no life- 
threatening  disease that  is as easily transmit- 
table to humans as salmonella in  poultry and 
fluoroquinolones  are not  approved for use in 
swine. Therefore, the lives saved with a  ban 
in  swine would likely  be less than in poultry. 
Lutter, Morrall, and Viscusi estimate that each 
Tahle 5.  Change in Producer and Consumer Surplus from Increaw in  Production Costs Due 
to  Banning Subtherapeutic Antibiotics in  Swine Only ($M) 
Producers  Consirrners 
Situation  Beef  Pork  Poultry  Beef  Porh  Poultry 
Ban, short run  14.3  -  153.5  7.0  -  14.3  X9.0  -7.0 
Ban, long run,'  15.5  -99.2  7.1  -  15.5  -143.2  -7.1 
Ban, long run1'  16.1  -62.4  5.5  -16.1  -  180.0  -5.5 
.'The elasticities of  farm \upply for beef. pork, and poultry are 0.5. 
Thc clarticities of  farm supply ('or beef. pork, ancl poultry are 0.7, 1. ancl  1.  rcspecttvely. 398  Journal  of Agric~~rlt~rul  a11(1 Ap~~lietl  G~orzornic..~,  Ilrc.c~tr~her  2002 
$ISM in income reduces mortality by one sta- 
tistical  death. Thus, a total  ban would cause 
16  statistical  deaths due to reduced  income 
and therefore the net effect of a ban might be 
an increase in mortality. There is also a posi- 
tive  probability  of  some  unforeseen  cata- 
strophic event.  But  Shogren (p.  314)  argues 
that the probabilities of such events are often 
overestimated. 
Conclusion 
A  ban on the use of  antimicrobial  agents as 
growth proniotantsfor swine would be costly, 
totaling $242.5  million  annuiilly, with swine 
producers bearing $153.5  million  of the cost 
in the short run. In the long run, the loss borne 
by consumers would likely be larger than the 
loss borne by producers. Based on a  30-year 
planning horizon and a 4% discount rate, the 
net  present  value  of  these  increased  costs 
would be $3.2 billion. 
The ban  considered here was a  complete 
ban  on all  microbial  agents. A  ban  that  in- 
cluded only the few antibiotics that are also 
used for humans might have little effect on the 
swine industry. Also, producers might be able 
to change management practices in unexpect- 
ed ways to compensate for the loss of anti- 
microbials. Thus, the actual losses from a ban 
might  be  smaller  than  the  losses  estimated 
here. 
It should be noted that wide ranges of pub- 
lished elasticity estimates were available. The 
elasticity  estimates determined  whether  pro- 
ducers or consumers incurred the cost of the 
ban.  Because  pork  production  uses  tew re- 
sources that  are specialized  and fixed  in the 
long run (although this may change with in- 
creasing regulation). its supply curve is likely 
elastic in the long run and so  consumers would 
incur more of the long-run cost of the ban. 
The estimates of the total  cost oP banning 
subtherapeutic antimicrobial use in swine were 
roughly  half  of that  estimated  by the Corn- 
rnittee on Drug Use in Food Animals (Nation- 
al Research Council  I99Xa). The key differ- 
ence was that  they  assumed  that  marketing 
cost  would  increase  proportionately  to  any 
change in production  cost, while this model 
held marketing costs constant. 
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